Exclusive Interview with MYNT: Targeting the Global Market and Promoting Smoke-Free Nicotine Products

2Firsts Events by 2FIRSTS
Sep.07.2024
Exclusive Interview with MYNT: Targeting the Global Market and Promoting Smoke-Free Nicotine Products
MYNT CEO Shivam Bihani shares company's journey in nicotine pouch industry, focusing on innovation and global expansion.

On September 6th, Shivam Bihani, the founder and CEO of the Indian nicotine pouch brand MYNT, shared the company's development history, market layout, and future prospects in an interview with 2Firsts. Founded 75 years ago, MYNT has been focusing on research and development and export business of nicotine pouches since entering the oral tobacco market in 2019. The company is committed to improving product taste and user experience through technological innovation.

 

The pharmaceutical background supports the layout of the nicotine pouch market

 

The predecessor of MYNT was a pharmaceutical company, which in 2019 decided to focus its energy on the nicotine pouch field. Shivam Bihani pointed out that the company's pharmaceutical experience has provided a solid foundation for the production and quality control of nicotine pouches, which is also one of the key factors that allow MYNT products to meet the strict standards of the European and American markets. The company's products are currently mainly exported to the European and American markets, as the sale of nicotine pouch products is not allowed in India. The company is optimistic about the potential for global development in the future.

 

MYNT faces strict regulatory requirements for the export of nicotine pouches. Shivam Bihani mentioned that the company had to comply with the FDA's PMTA (Pre-Market Tobacco Product Application) requirements when entering the US market, which not only consumed a significant amount of time and money, but also posed challenges for the company's global expansion. In addition to the US, MYNT also needs to adhere to export qualification restrictions in other countries, further emphasizing the importance of global compliance in the nicotine pouch industry.

 

The company's focus is on the markets in the UK and Malaysia

 

MYNT's nicotine pouch products come in two packaging forms: pouches and boxes, to meet the needs of different consumers. Shivam Bihani emphasizes that through technological innovation, MYNT is able to provide consumers with a better taste experience, which is one of the company's core competitive advantages. Additionally, the company pays attention to the design of the packaging and has obtained relevant patents for protection.

 

Exclusive Interview with MYNT: Targeting the Global Market and Promoting Smoke-Free Nicotine Products
MYNT bagged products | Image source: 2Firsts

 

Exclusive Interview with MYNT: Targeting the Global Market and Promoting Smoke-Free Nicotine Products
MYNT box-packaged product | Image source: 2Firsts

 

During the exhibition in Malaysia, MYNT expressed a strong intention to develop global exports. Shivam Bihani revealed that the company's current focus is on the UK and Malaysian markets. He believes that as nicotine pouch products gradually become more popular worldwide, more nicotine users will be able to break the habit of smoking and reduce the health risks associated with traditional tobacco products.

 

Confidence in the Future of Nicotine Pouches

 

Shivam Bihani is confident in the future of nicotine pouches. He believes that despite being a new nicotine product like e-cigarettes, there are significant differences between the two in the market, they are very different. Nicotine pouches are becoming increasingly popular among global consumers due to their smoke-free and convenient characteristics, and they have huge market potential.

 

In regards to the company's development plan, Shivam Bihani stated that the company will continue to focus on the nicotine pouch sector and will not consider expanding into the chewing gum or other compressed product categories. In the future, they will continue to cultivate this market and provide high-quality, safe smokeless nicotine products for consumers worldwide.

 

MYNT's global strategy not only demonstrates the potential of Indian companies in the nicotine pouch field, but also provides new ideas for the global development of the nicotine pouch industry.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
Product | BAT Launches VELO WRKS Nicotine Pouches in Sweden, Introducing Dual-Compartment Cans With Two Flavours
Product | BAT Launches VELO WRKS Nicotine Pouches in Sweden, Introducing Dual-Compartment Cans With Two Flavours
British American Tobacco (BAT)'s VELO brand launched the VELO WRKS nicotine pouch range in Sweden on November 2, 2026. The initial release features three Dual Can variants, each containing two separate flavours in a dual-compartment container. Each can holds 20 slim pouches with 8mg of nicotine per pouch and retails for SEK 52.99. According to VELO, the first release, Drop 1, is limited to 75,000 cans and will remain available until February 2027 or while stocks last. VELO positions WRKS as a platform for testing new product concepts and has introduced an online consumer feedback survey. EU trademark records show BAT applied to register VELO WRKS in March 2026 under Class 34, covering nicotine pouches, e-cigarettes, heated tobacco products and other tobacco-related goods.
product
Nov.03
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Former cigarette smokers accounted for an estimated 54% of current e-cigarette users in Great Britain in 2025, while 26% also smoked cigarettes and 20% had never regularly smoked, according to a 2Firsts analysis of Office for National Statistics (ONS) data. Among former cigarette smokers who currently vape, approximately 81% used e-cigarettes daily, compared with about 50% of dual users. The ONS found that 33.8% of current cigarette smokers also vaped in 2025, up from 10.6% in 2014. Approximately 1.1 million adults who had never regularly smoked cigarettes used e-cigarettes, representing 2.9% of that population, compared with 0.2% in 2014. The figures highlight differences in the composition, frequency of use and long-term trends across Britain's vaping population.
DATA
Oct.14
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
A U.S. International Trade Commission (USITC) administrative law judge issued an initial determination on October 20, 2026, finding that certain Glas vaping devices, cartridges and components infringed 12 claims across two patents asserted by JUUL, constituting a violation of Section 337 of the Tariff Act of 1930. The judge recommended a limited exclusion order and a cease and desist order against the Glas respondents. Five months earlier, the FDA authorized four Glas e-cigarette pods, including mango, blueberry and two menthol variants. The patent investigation concerns device and cartridge structures and is separate from FDA premarket review. The proposed import restrictions have not become final, and their product-level scope remains unresolved.
company
Nov.05
EU Vape, Heated Tobacco and Nicotine Pouch Tax Reform Reaches Ministerial Talks: Sweden Opposes Proposed 2032 Minimum of 50% of Retail Price or €50/kg for Nicotine Pouches
EU Vape, Heated Tobacco and Nicotine Pouch Tax Reform Reaches Ministerial Talks: Sweden Opposes Proposed 2032 Minimum of 50% of Retail Price or €50/kg for Nicotine Pouches
EU finance ministers are scheduled to discuss tobacco excise reform on November 9, 2026, seeking agreement on higher minimum duties for conventional tobacco and a common EU minimum tax framework covering e-cigarettes, heated tobacco and nicotine pouches. A November 5 Council document identifies nicotine pouch taxation as the main outstanding issue. The Irish Council presidency proposes phased increases, reaching 50% of retail selling price or €50 per kilogram in 2032. Sweden has formally said it cannot support the current compromise, objecting to both the proposed nicotine pouch tax burden and the adjustment of minimum rates based on national purchasing power. The package also addresses cross-border personal-use reference quantities, raw tobacco controls and the continued exclusion of traditional tobacco snus.
Regulations
Nov.10